Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia

Name: Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia
SKU: 24172
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 51 No. 2 Articles 2021 Tags: antipsychotic, Atsuhiro Miyazawa, Atsushi Kimura, cortical inhibition, gaba, Hiroshi Kimura, Hiroyuki Watanabe, Masaomi Iyo, Nobuhisa Kanahara, Satoshi Kodama, transcranial-magnetic-stimulation, treatment-resistant, Yasunori Oda, Yusuke Nakata

Description

Description

Original Research

Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia

By Atsuhiro Miyazawa, Nobuhisa Kanahara, Yusuke Nakata, Satoshi Kodama, Hiroshi Kimura, Atsushi Kimura, Yasunori Oda, Hiroyuki Watanabe, Masaomi Iyo

Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia

Description

Original Research

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Psychopharmacology Bulletin VOL 49 No. 2, 2019 – Full Issue Stacked PDF

Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit

Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study

Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia

Description

Original Research

Related products

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Psychopharmacology Bulletin VOL 49 No. 2, 2019 – Full Issue Stacked PDF

Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit

Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study